X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1196) 1196
Publication (89) 89
Book / eBook (40) 40
Book Review (31) 31
Book Chapter (21) 21
Newspaper Article (6) 6
Magazine Article (4) 4
Newsletter (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (750) 750
index medicus (660) 660
female (364) 364
male (364) 364
adult (265) 265
middle aged (263) 263
soft-tissue infections (263) 263
infectious diseases (224) 224
health aspects (214) 214
surgery (196) 196
aged (194) 194
skin (191) 191
anti-bacterial agents - therapeutic use (176) 176
microbiology (171) 171
analysis (166) 166
pharmacology & pharmacy (141) 141
treatment outcome (140) 140
adolescent (134) 134
antibiotics (133) 133
resistant staphylococcus-aureus (132) 132
epidemiology (131) 131
infections (131) 131
staphylococcus aureus (130) 130
animals (129) 129
risk factors (128) 128
research (127) 127
retrospective studies (119) 119
soft tissue infections - drug therapy (114) 114
care and treatment (111) 111
management (109) 109
staphylococcus aureus infections (100) 100
bacteria (99) 99
child (99) 99
infection (95) 95
mortality (95) 95
vancomycin (94) 94
young adult (93) 93
soft tissue infections - microbiology (92) 92
aged, 80 and over (90) 90
complicated skin (90) 90
methicillin-resistant staphylococcus aureus (88) 88
staphylococcus infections (83) 83
medicine (81) 81
medicine & public health (81) 81
orthopedics (77) 77
skin diseases, bacterial - drug therapy (75) 75
soft tissue infections - epidemiology (75) 75
diagnosis (74) 74
research article (73) 73
risk-factors (73) 73
prevalence (72) 72
mrsa (71) 71
child, preschool (70) 70
therapy (70) 70
medical research (68) 68
prospective studies (68) 68
soft-tissue (68) 68
hospitals (67) 67
internal medicine (66) 66
linezolid (65) 65
wound healing (65) 65
united-states (63) 63
staphylococcal infections - drug therapy (62) 62
usage (62) 62
dermatology (61) 61
anti-bacterial agents - administration & dosage (60) 60
pathogens (60) 60
patients (59) 59
soft rot (58) 58
drug resistance in microorganisms (57) 57
studies (57) 57
medicine, experimental (55) 55
staphylococcal infections - microbiology (55) 55
infant (54) 54
drug resistance (53) 53
medicine, general & internal (53) 53
plant sciences (53) 53
staphylococcal infections - epidemiology (53) 53
staphylococcal skin infections - drug therapy (53) 53
children (52) 52
oncology (52) 52
soft tissues (52) 52
anti-bacterial agents - pharmacology (51) 51
diabetes (51) 51
methicillin-resistant staphylococcus aureus - isolation & purification (51) 51
drug therapy (50) 50
staphylococcal skin infections - microbiology (50) 50
cancer (48) 48
immunology (48) 48
hospitalization (46) 46
care (45) 45
cellulitis (45) 45
length of stay (45) 45
dentistry (44) 44
infectious disease (44) 44
nosocomial infections (44) 44
public health (44) 44
amputation (43) 43
disease (43) 43
risk (43) 43
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (26) 26
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
UofT at Scarborough - Stacks (3) 3
Mathematical Sciences - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1257) 1257
German (7) 7
Spanish (3) 3
Czech (1) 1
Danish (1) 1
French (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetologia, ISSN 0012-186X, 5/2010, Volume 53, Issue 5, pp. 914 - 923
Skin and soft tissue infections (SSTIs) cause substantial morbidity in persons with diabetes. There are few data on pathogens or risk factors associated with... 
Medicine & Public Health | Human Physiology | Foot infections | Skin and soft tissue infection | Mortality | Metabolic Diseases | MRSA | Hospitalised patients | Internal Medicine | Diabetes | Length of stay | UNITED-STATES | RESISTANT STAPHYLOCOCCUS-AUREUS | COMPLICATED SKIN | SURGICAL SITE | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | ECONOMIC OUTCOMES | LARGE US DATABASE | EPIDEMIOLOGY | PATHOGENS | Pseudomonas Infections - economics | Soft Tissue Infections - etiology | Diabetes Complications - microbiology | Pseudomonas Infections - etiology | Prevalence | Length of Stay - economics | Staphylococcal Skin Infections - epidemiology | Humans | Risk Factors | Soft Tissue Infections - economics | Iatrogenic Disease - economics | Diabetes Complications - economics | Soft Tissue Infections - epidemiology | Diabetes Mellitus - microbiology | Pseudomonas - isolation & purification | Inpatients | Health Care Costs | Diabetes Mellitus - economics | Staphylococcal Skin Infections - etiology | Pseudomonas Infections - epidemiology | Diabetes Complications - epidemiology | Iatrogenic Disease - epidemiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Staphylococcal Skin Infections - economics | Diabetics | Patient outcomes | Diabetic foot | Staphylococcus aureus infections | Risk factors | Medical care, Cost of | Medical colleges | Hospitals | Skin | Foot diseases
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 04/2018, Volume 51, Issue 4, pp. 571 - 577
Dalbavancin is a lipoglycopeptide with a very prolonged half-life enabling treatment with a single intravenous administration that has been approved to treat... 
Gram-positive infection | Skin and soft-tissue infection | Dalbavancin | SOFT-TISSUE INFECTIONS | INFECTIOUS DISEASES | MANAGEMENT | ONCE-WEEKLY DALBAVANCIN | MICROBIOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | COMPLICATED SKIN | ACUTE BACTERIAL SKIN | SKIN-STRUCTURE INFECTIONS | PARENTERAL ANTIMICROBIAL THERAPY | PHARMACOLOGY & PHARMACY | CONVENTIONAL THERAPY | CLINICAL-OUTCOMES | Humans | Middle Aged | Soft Tissue Infections - economics | Male | Teicoplanin - therapeutic use | Osteomyelitis - drug therapy | Prosthesis-Related Infections - drug therapy | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Staphylococcal Skin Infections - drug therapy | Prosthesis-Related Infections - economics | Prosthesis-Related Infections - microbiology | Enterococcus - isolation & purification | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Soft Tissue Infections - drug therapy | Teicoplanin - analogs & derivatives | Catheter-Related Infections - economics | Osteomyelitis - economics | Methicillin-Resistant Staphylococcus aureus - drug effects | Catheter-Related Infections - drug therapy | Spain | Teicoplanin - adverse effects | Soft Tissue Infections - microbiology | Osteomyelitis - microbiology | Catheter-Related Infections - microbiology | Cost-Benefit Analysis | Aged | Enterococcus - drug effects | Methicillin-Resistant Staphylococcus aureus - isolation & purification
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2014, Volume 44, Issue 1, pp. 56 - 64
Abstract This retrospective observational medical chart review aimed to describe country-specific variations across Europe in real-world meticillin-resistant... 
Infectious Disease | Linezolid | Economics | Intravenous line days | Vancomycin | Intravenous-to-oral antibiotic switch | Length of stay | INFECTIOUS DISEASES | EFFICACY | MICROBIOLOGY | DAPTOMYCIN | THERAPY OPAT | IMPACT | PHARMACOLOGY & PHARMACY | Injections, Intravenous | Length of Stay - economics | Humans | Middle Aged | Patient Discharge | Soft Tissue Infections - economics | Hospitalization - statistics & numerical data | Male | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Staphylococcal Skin Infections - drug therapy | Acetamides - therapeutic use | Soft Tissue Infections - pathology | Adult | Female | Acetamides - economics | Retrospective Studies | Soft Tissue Infections - drug therapy | Length of Stay - statistics & numerical data | Anti-Bacterial Agents - economics | Drug Administration Schedule | Administration, Oral | Europe | Methicillin-Resistant Staphylococcus aureus - drug effects | Staphylococcal Skin Infections - pathology | Oxazolidinones - economics | Vancomycin - economics | Methicillin-Resistant Staphylococcus aureus - growth & development | Soft Tissue Infections - microbiology | Vancomycin - therapeutic use | Aged | Staphylococcal Skin Infections - microbiology | Hospitalization - economics | Practice Guidelines as Topic | Staphylococcal Skin Infections - economics | Medical colleges | Care and treatment | Analysis | Staphylococcus aureus infections | Health care reform | Skin | Health aspects | Staphylococcus aureus | Medical care, Cost of
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, p. e0149960
Complicated skin and soft tissue infections (cSSTI) are some of the most commonly treated infections in hospitals, and place heavy economic burdens on patients... 
EUROPE | HOSPITALIZED-PATIENTS | TIGECYCLINE | MANAGEMENT | VANCOMYCIN | EFFICACY | SAFETY | MULTIDISCIPLINARY SCIENCES | RESISTANT STAPHYLOCOCCUS-AUREUS | PATHOGENS | DAPTOMYCIN | Klebsiella pneumoniae - drug effects | Length of Stay - economics | Escherichia coli - drug effects | Humans | Middle Aged | Soft Tissue Infections - economics | Cost of Illness | Male | Treatment Outcome | Skin Diseases, Bacterial - drug therapy | Skin Diseases, Bacterial - economics | China - epidemiology | Soft Tissue Infections - epidemiology | Anti-Bacterial Agents - therapeutic use | Inpatients | Skin Diseases, Bacterial - epidemiology | Drug Resistance, Multiple, Bacterial | Female | Aged | Retrospective Studies | Soft Tissue Infections - drug therapy | Staphylococcus aureus - drug effects | Hospitalization - economics | Hospital patients | Infectious skin diseases | Research | Demographic aspects | Risk factors | Diseases | Linezolid | Fluoroquinolones | Economic analysis | Microbiology | Medical services | Medical records | Gram-positive bacteria | Population studies | Infections | Vancomycin | Drug resistance | Epidemiology | Clinical outcomes | Methicillin | Immunology | Cephalosporins | E coli | Penicillin | Bacteria | Gram-negative bacteria | Medical treatment | Staphylococcus infections | Antimicrobial agents | Hospitalization | Patients | Medicine | Chemotherapy | Hospitals | Infectious diseases | Antibiotics | Skin | Electronic health records | Imipenem
Journal Article
Journal of the American Board of Family Medicine, ISSN 1557-2625, 09/2013, Volume 26, Issue 5, pp. 508 - 517
Journal Article
Journal of Pediatric Surgery, ISSN 0022-3468, 2011, Volume 46, Issue 10, pp. 1935 - 1941
Abstract Background The number of children requiring treatment of skin and soft tissue infections (SSTIs) has increased since the emergence of... 
Pediatrics | Surgery | Incision and drainage | Skin and soft tissue infections | Pediatric | Methicillin-resistant Staphylococcus aureus | UNITED-STATES | SURGERY | VISITS | PEDIATRICS | RESISTANT STAPHYLOCOCCUS-AUREUS | EMERGENCE | TRENDS | EPIDEMIOLOGY | United States - epidemiology | Age Distribution | Humans | Soft Tissue Infections - economics | Child, Preschool | Hospitalization - statistics & numerical data | Staphylococcal Infections - surgery | Infant | Skin Diseases, Infectious - epidemiology | Incidence | Methicillin-Resistant Staphylococcus aureus | Skin Diseases, Infectious - microbiology | Soft Tissue Infections - surgery | Skin Diseases, Infectious - economics | Skin Diseases, Infectious - surgery | Patient Discharge - statistics & numerical data | Retrospective Studies | Child | Databases, Factual | Hospital Costs - statistics & numerical data | Insurance Coverage - statistics & numerical data | Soft Tissue Infections - epidemiology | Drainage - statistics & numerical data | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Staphylococcal Infections - economics | Hospitalization - trends | Adolescent | Continental Population Groups - statistics & numerical data | Drainage - economics | Hospitalization - economics | Dermatologic agents | Skin | Dermatology | Formulae, receipts, prescriptions | Staphylococcus aureus infections
Journal Article
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 2014, Volume 79, Issue 2, pp. 266 - 272
Journal Article
American Surgeon, ISSN 0003-1348, 11/2015, Volume 81, Issue 11, pp. E376 - E378
  There were several, all with a significant financial impact. [...]I&D led to resolution of all abscesses regardless of the organism and postoperative... 
SURGERY | SKIN | CHILDREN | Drainage | Soft Tissue Infections - diagnosis | Soft Tissue Infections - surgery | Humans | Adolescent | Soft Tissue Infections - economics | Child, Preschool | Female | Infant | Male | Hospitalization | Child | Wound healing | Antibiotics | Laboratories | Surgery | Staphylococcus infections | Cost control
Journal Article
Journal Article